VivoSim Labs, Inc.
VIVS
$2.11
$0.136.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 94.52% | 32.11% | -49.59% | -72.01% | -83.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.52% | 32.11% | -49.59% | -72.01% | -83.60% |
| Cost of Revenue | -5.73% | -33.54% | -60.97% | -63.57% | -59.50% |
| Gross Profit | 7.66% | 34.87% | 61.25% | 63.24% | 58.32% |
| SG&A Expenses | -15.95% | -20.28% | -26.47% | -21.55% | -5.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.38% | -16.03% | -36.63% | -35.04% | -24.99% |
| Operating Income | 14.93% | 16.37% | 36.48% | 34.34% | 23.60% |
| Income Before Tax | 85.79% | 83.05% | 35.11% | 33.10% | 22.61% |
| Income Tax Expenses | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 85.79% | 83.04% | 35.11% | 33.09% | 22.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.79% | 83.04% | 35.11% | 33.09% | 22.60% |
| EBIT | 14.93% | 16.37% | 36.48% | 34.34% | 23.60% |
| EBITDA | 15.05% | 16.59% | 37.02% | 34.68% | 23.85% |
| EPS Basic | 92.88% | 86.28% | 62.08% | 51.56% | 33.30% |
| Normalized Basic EPS | 57.68% | 56.68% | 62.39% | 51.85% | 33.48% |
| EPS Diluted | 92.88% | 86.28% | 62.08% | 51.56% | 33.30% |
| Normalized Diluted EPS | 57.68% | 56.68% | 62.39% | 51.85% | 33.48% |
| Average Basic Shares Outstanding | 102.01% | 41.57% | 7.61% | 8.16% | 5.12% |
| Average Diluted Shares Outstanding | 102.01% | 41.57% | 7.61% | 8.16% | 5.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |